IVDR stands for In Vitro Diagnostic Regulation, which is a set of rules governing in vitro diagnostic medical devices in the European Union. This regulation aims to ensure the safety and performance of diagnostic tests used outside the human body, such as blood tests, urine analysis, and genetic screening.
The IVDR establishes a new regulatory framework for manufacturers, importers, and distributors of in vitro diagnostic devices. It introduces stricter requirements for clinical evidence, post-market surveillance, and traceability of devices throughout the supply chain, enhancing patient safety and healthcare quality.
IVDR is crucial in clinical research as it directly impacts the development, validation, and use of diagnostic tests in clinical trials. It ensures that in vitro diagnostic devices used in research meet high standards of quality and reliability, which is essential for generating accurate and trustworthy clinical data.
Understanding IVDR is important for researchers and sponsors to navigate regulatory compliance and market access for new diagnostic technologies. It influences study design, data collection methods, and the overall conduct of clinical investigations involving in vitro diagnostic devices, particularly in the European Union.
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
Copyright @ 2026 Axcellant